PharmaCyte Biotech, Inc. (PMCB)

0.9971 -0.04 (-4.12%) USD  |  NASDAQ  |  Dec 11, 10:02
More

PharmaCyte Biotech Enterprise Value: -6.373M for Dec. 10, 2025

Enterprise Value Chart

View Enterprise Value for PMCB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Lunai Bioworks, Inc. 29.67M
Kala Bio, Inc. 15.17M
Femasys, Inc. 54.30M
CEL-SCI Corp. 27.99M
AIM ImmunoTech, Inc. 1.037M

Enterprise Value Related Metrics

Net Income (Quarterly) -8.360M
Total Expenses (Quarterly) 8.360M
EPS Diluted (Quarterly) -1.230
Earnings Yield -46.04%
Normalized Earnings Yield -65.51